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To determine the necessity of a single dose prophylactic antibiotic in preventing the 
postoperative infective complications in patients undergoing elective laparoscopic 
cholecystectomy. 
Methods 
All consecutive patients who underwent laparoscopic cholecystectomy (LC) at King Saud 
Medical City from 1 January 2010 to 1 May 2011 were considered for this prospective 
randomized controlled study. Patients who were included in this study were prospectively 
randomized into two groups: those receiving single dose of intravenous Cefuroxime 1.5 gm, 
30 minute before surgery (group A) and those  not receiving  any preoperative antibiotic 
(group B). Postoperative infective complications were recorded and compared for both 
groups. 
Results 
One hundred and twelve patients received antibiotics (group A), and 109 patients did not 
received any antibiotics (group B). In group A, 3 patients developed umbilical port site 
infection whereas in group B, 5 patients developed infection (four in the umbilical port site 
and one in the epigastric port site). The differences in the infection rate between the two 
groups were not significant. Intraoperative gallbladder perforation and positive bile culture 
was not found to increase the rate of surgical site infection. 
Conclusion 
The elimination of prophylactic antibiotics in patients undergoing elective LC increase the 
incidence of postoperative infective complications but not to a statistically significant degree. 
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Introduction 
  
urgical site infections (SSIs) is a 
significant postoperative complication 
that can result in considerable morbidity 
and mortality1. The use of prophylactic 
antibiotics for various clean contaminated 
surgical procedures is commonly used to 
reduce the risk of postoperative infective 
complications and, hence to improve the 
results of surgical procedures. At present, 
laparoscopic cholecystectomy (LC) is the 
gold standard for treatment of gallstone 
disease2.  LC has a low risk for postoperative 
infective complications. The use of 
antibiotics prophylaxis to prevent SSIs has 
been questioned3-6. On contrary, the 
administration of prophylactic antibiotics is 
still recommended by many surgeons in 
elective LC7-9. The aim of this study was to 
determine the necessity of single dose 
prophylactic antibiotics in preventing the 
postoperative infective complications in 
patients undergoing elective LC. 
 
Material and Methods 
 
All consecutive patients who underwent LC 
at King Saud Medical City from 1 January 
2010 to 1 May 2011 were considered for this 
prospective randomized controlled study. 
Patients were randomized into those 
receiving single dose of Cefuroxime 1.5 gm 
IV 30 min. before surgery and those not 
receiving any preoperative antibiotic. This 
randomization was done by placing 
instruction whether to give ‘prophylactic 
antibiotic’ or ‘no antibiotic’ in closed 
envelops which were then mixed up. These 
envelops were opened by a responsible 
ward nurse to carry out the instruction 
before transferring patients to operation 
theatre for LC. Patients who received single 
preoperative dose of prophylactic antibiotics 
were labeled as group A while patients not 
given prophylactic antibiotics were placed 
in group B. Patients  were excluded from the 
study if they had any of the following 
exclusion criteria: acute cholecystitis, 
evidence of obstructive jaundice and/or 
cholangitis, body mass index ≥ 30, diabetes 
mellitus, age above 60 year, preoperative 
endoscopic or percutaneous biliary 
intervention, use of antibiotics within one 
week of the planned LC, ASA higher than 
score 2, Leucocytosis on admission (WBC ≥ 
11 x 10) documented fever ≥ 38 0C within one 
week of the planned LC, liver cirrhosis, 
regular corticosteroid intake, cardiac valvular 
disease, biliary pancreatitis, and conversion 
to open cholecystectomy. All patients includ-
ed in this study gave their consent for 
participation in the study. Ethical approval 
was obtained from the Research Ethics 
Committee of the hospital before commen-
cement of this study9.  
On the morning of surgery all patients 
underwent umbilical cleansing with 10% 
Povidone-Iodine solution. A nasogastric tube 
was inserted after the induction of anesthesia 
and removed at the end of surgery in all 
patients. Urinary bladder catheterization was 
not performed in any patient. At surgery the 
skin was prepared with 10% solution of 
Povidone Iodine in all patients. Laparoscopic 
cholecystectomy was performed using four 
operating ports by consultant surgeon or 
senior resident supervised by consultant 
surgeon. Pneumo-peritoneum were created 
in all patients by a closed method through an 
infra-umbilical incision. Local peritoneal 
lavage with 500-1000 cc of normal saline was 
performed in cases of gallbladder perforation 
with bile leak and/or spillage of stones. 
Spilled stones were retrieved in endobag 
whenever possible.  One sub-hepatic Jackson-
Pratt drainage tube was inserted whenever 
perforated gallbladder with bile leak and/or 
stones spillage was encountered. The 
gallbladder was removed through the 
epigastric operating port in all patients, with 
the use of an endobag in cases of perforated 
gallbladder. Povidone iodine 10% solution 
was used to cleanse the wound of all port 
sites before the closure in all patients. The 
umbilical and epigastric ports were closed 
with 2/0 non-absorbable monofilament 
sutures. A sample of bile was collected with 
sterile syringe from the gallbladder for 
aerobic and anaerobic culture immediately 
after its removal from the abdomen in all 
patients. No additional dose of antibiotics 
was given during or after surgery in either 
patient group.  
S 
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Infective complications were defined as: 
clinical features indicating the presence of 
infection with or without positive pathogen 
culture within 30 days of surgery. Infection 
sites were classified as:  
1. Superficial wound infection (signs of 
inflammation with or without 
discharges/collection)  
2. Deep seated infection in the form of 
collection or abscesses in the abdominal 
cavity and 
3. Distant infections away from the surgical 
site, such as respiratory and urinary tract 
infections.  
Majority of patients were discharged on 1st 
post-operative day except for those who had 
abdominal drain. However, all patients 
were discharged within 3 days after LC. All 
patients were followed up in the outpatient 
clinic with weekly clinical (and laboratory if 
indicated) evaluation for any evidence of 
infective complication for 30-days period. 
Bacteriological swabs were taken from all 
infected wound sites and the cultured 
organisms were recorded. Oral antibiotics 
and wound care were given to patients who 
developed SSI until complete wound 
healing.   
The following data were collected for each 
patient: age, gender, body weight, ASA 
score, intraoperative gallbladder perforation 
with bile leak and/or stones spillage, 
duration of surgery, postoperative hospital 
stay, results of bile cultures, type of infective 
complications and its treatment.  
We have used the Statistical Package for the 
Social Sciences (SPSS) ver. 17.0 to perform 
data analysis. We used the Student t-test 
with two independent groups to compare 
between Group A and Group B for 
continuous (Numerical) variables, we also 
used the Chi-square test and Fisher's Exact 
test to compare between Group A and 
Group B with Nominal (Non-numerical) 
variables. We assumed statistically a 




During the study period, two hundred and 
twenty four (n=224) patients were included 
in the study. Patients were equally distri-
buted: 112 in each group. Group A consisted 
of 23 males and 89 females and Group A of 
17 males and 95 females. However, three 
patients (two male and one female) were 
excluded from Group B after randomization 
due to the conversion to open 
cholecystectomy and excluded from the data 
analysis (Figure 1). The reason for 
conversion in the female patient was due to 
injury of the common hepatic duct while the 
two male patients had unclear anatomy. The 
differences in patients' characteristics and 
the number of posto-perative infective 
complications in the two groups were not 
significant (Table 1). Intraoperative 
gallbladder perforation was encountered in 
41 patients, 23 in Group A and 18 in Group 
B. The difference was not statistically 
significant between both groups (P = 0.439). 
The overall rate of postoperative infective 
complications was 8 out of 221 (3.62%) 
patients. In Group A 3 patients (2.7%) 
developed superficial SSI in the umbilical 
port site with purulent fluid accumulation. 
None of them had intraoperative 
gallbladder perforation. In Group B 5 
patients (4.6 %) developed superficial SSI 
(four in the umbilical port site and one in 
the epigastric port site) with purulent fluid 
accumulation. Only one of them had 
gallbladder perforation with bile spillage. 
The difference between both groups was not 
statistically significant (P = 0.346). No other 
postoperative infective complication such as 
urinary tract infection, pneumonia, 
abdominal abscess was seen among the 
study group.  The results of bile culture 
were positive in 39 (35 %) patients in Group 
A and 43 patients (39 %) in Group B. The 
difference was not statistically significant (P 
= 0.476). The most commonly cultured 
microorganism was Escherichia coli, 
followed by Klebsiella pneumonia. The 
swab cultures from the infected wounds 
were negative in all patients who developed 
superficial wound infection. Only one 
patient with intraoperative gallbladder 
perforation developed superficial wound 
infection; however the wound swab culture 
was also negative in this patient. 
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Figure 1: Flow chart showing patients distribution. 
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Table 1: Patient characteristics and postoperative infective complications. 
 
Characteristics of patients Group A (n = 112) 
Group B 
(n = 109) P-Value 
Gender (M/F) 23/89 15/94 (0.182) * 
Mean Age (y) 41.3 + 22.6 39.7 + 22.3 (0.596)*** 
Body Weight (Kg) 70.3 + 9.72 72.1 + 8.65 (0.147)*** 
ASA score (I/II) 99/13 94/15 (0.630) * 
Infected bile n (%)  39 (35) 43 (39) (0.476) * 
Bile and /or gallstones spillage n (%) 23 (20.5) 18 (16.5) (0.442) * 
Duration of Surgery (min) 65 + 29.7 71.1 +  33.8 (0.155)*** 
Length of hospital stay (d) 1.211  + 0.433 1.323 + 0.325 (0.062)*** 
SSI      
1) Superficial wound infections n (%) 3 (2.7 ) 5 (4.6 ) (0.346) ** 
2) Intra-abdominal collections  0 0 _ 
 Distant infections 0  0 _ 
* By Chi-square Test   **By Fisher's Exact Test         ***By Student t-test for independent groups 
 




The use of prophylactic antibiotics in open 
cholecystectomy to reduce the rate of 
postoperative infective complications is 
considered to be the standard of practice. 
However, its use in LC has been evaluated 
by many studies with controversial results. 
Several studies have recommended the use 
of prophylactic antibiotics stating that it 
significantly reduces the incidence of 
postoperative infective complications8,10-11. 
On the contrary several prospective studies 
have concluded that the use of prophylactic 
antibiotics in low-risk patients undergoing 
LC is unnecessary, because the rate of 
postoperative infective complications is 
already low in such patients, and therefore 
the use of prophylactic antibiotics will not 
reduce the rate of postoperative infective 
complications significantly2,6,12-14. It has been 
reported in the literature that the average 
rate of SSI after LC to be 0.4 – 6.3% although 
a higher rate of SSI has been reported after 
open cholecystectomy3-5,8,15-16. In this study 
the overall postoperative infective 
complications was 3.62% (2.7 % in Group A 
and 4.6 % in Group B) with no significant 
statistical difference between the two 
groups. All infective complications were 
superficial wound infection and all were 
treated with pus drainage, wound care and 
antibiotics. No deep incisional, deep seated 
or distant infections were reported in this 
study.                                                            
When the duration of surgery extended 
longer than 2 to 3 hours additional doses of 
prophylactic antibiotics are recommended in 
open cholecystectomy17. The mean operative 
time in elective LC is usually less than 2 
hours18-19. In this study the duration of 
surgery was less than 2 hours in all patients 
of both groups. No further doses of antibiotic 
were given postoperatively to any patient. 
The role of positive bile culture, bile and 
stones spillage due to intraoperative 
gallbladder perforation on the occurrence of 
SSI is still controversial. Intraoperative 
gallbladder perforation has been reported to 
occur in 11% to 20% of LC20,21. The rate of 
positive bile culture among patients with 
gallbladder stones has been found to range 
between 10% and 42.5%3-4,8,10-11. In this study 
bile spillage due to gallbladder perforation 
occurred in 18.5% (n=41) of patients whereas 
the bile culture was positive for micro-
organism in 37% (n=82).  Several studies 
have stated that both bactibilia and 
intraoperative gallbladder perforation were 
strongly associated with occurrence of SSI8,11. 
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However, many other studies did not 
observe this association, concluding that 
both bactibilia and intraoperative 
gallbladder perforation with bile and stones 
spillage does not increase the rate of SSI2-
4,6,21-22. In our study as well, no such 
association was observed. Only one patient 
with intraoperative gallbladder perforation 
and positive bile culture developed 
superficial wound infection, although the 
wound swab culture was negative. There 
was no relationship between the isolated 
organisms from the bile and the SSI culture 
results in several studies2-3,9.  However, this 
relationship could not be assessed in our 
study due to the negative wound swab 
culture in all patients who developed 
postoperative superficial wound infection. 
 
Conclusion 
In conclusion, the results of this study have 
shown that the elimination of prophylactic 
antibiotics in patients undergoing elective 
LC increases the incidence of postoperative 
infective complications but not to a statisti-
cally significant degree.  
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